pfizer stock

Pfizer stock price today is 39.15 USD with a volume of 18,955,544. At the same time, its chart fluctuates between  39.01 USD – 39.50 USD. Pfizer stock price was a maximum of 43.08 USD and a minimum of 29.99 USD within 52 weeks.  Its average volume is 27,591,895 and it is ranked 219.15B in the MarketCap listings. The target point of Pfizer stock price at the end of 1 year is 42.62 USD.

The company has been authorized to vaccinate 12-year-old children against Covid in the USA and Europe. This had a positive impact on Pfizer stock. A compelling factor for Pfizer stocks was the support of President Joe Biden and US Trade Representative Ambassador Katherine Tai to waive their patent rights protecting Covid vaccines. Due to this support, the company was under pressure, but the company’s aim was that different countries could benefit from their vaccines.

Companies regularly and actively notify the Food and Drug Administration to gain full approval for Covid vaccines. Thus, they will be able to stay in the market after the pandemic is over. In addition, companies may market the vaccine to other companies or change its price.

Pfizer’s goal is to have positive results from studies on children aged 6 months to 11 years this year. Pfizer announced that, as of mid-April, it has signed deals for 1.6 billion doses this year.

Pfizer Inc.

pfizer stock price

Pfizer Inc. is an American multinational pharmaceutical company headquartered in New York. The company was founded by Charles Pfizer (1824-1906) and is named after its founder’s surname.

Pfizer develops and manufactures drugs and vaccines for many different branches such as immunology, oncology, cardiology, endocrinology and neurology. The company has numerous blockbuster drugs or products, each generating more than $1 billion in annual revenue. The company’s 2020 revenue distribution was 52% from the USA, 6% from China and Japan, and 42% from other countries.

The company which was ranked 64th in the Fortune 500 lists and 49th in the Forbes Global lists, continued to exist as a component of the Dow Jones Industrial Average stock market index from 2004 to 2020.

In the first quarter of 2021, Pfizer earnings were up 47% year-over-year. It was 93 cents per stock and sales were up 45% to $14.58 billion. In particular, the biggest factor in these earnings was the Covid-19 vaccines, because the Covid vaccine brought sales of $ 3.46 billion to the company.

Analysis of Pfizer Stock

pfizer stock

Pfizer stock dropped to the buy point at $39.77 on May 3, but later returned to buy zones in the first half of May. Now, Pfizer stock is forming a fresh entry at $41.19.

Pfizer stocks were above the 50-day and 200-day moving averages in midday trading on June 1. The 1-99 measure scores a stock’s key growth metrics against all other stocks, and Pfizer stock has an IBD Composite Rating of 60. According to IBD Digital, stocks with a score of 95 or higher have a better CR. Pfizer stock surpassed 35% of all stocks for performance in the RS Rating.

EPS Rating compares a stock’s earnings growth in recent and long-term environments with other stocks and determines a rating for that stock accordingly. The company’s EPS Rating is 70 out of 99.

Should You Buy Pfizer Stock?

According to the CAN SLIM investment rules, Pfizer stock cannot be traded in the market at the moment, as the stocks have not yet exceeded the new purchase points. Once it reaches these points and is within the 5% trailing zone, the stock will be at its best buy point. Also after reaching this point, the company is expected to report bullish growth in the second quarter.

Pfizer stock performance should be watched when a major competitor like BioNTech is in the market. The results of the investigations made so far are promising for Pfizer.